The MRA Policy Pulse
24 July 2013 In News
With our office based in Washington, DC, we have numerous opportunities to contribute to efforts aimed at policy-makers urging them to ensure better outcomes for melanoma patients and those at risk. Whether we are advocating for increased NIH funding, participating in meetings on Capitol Hill, or highlighting the need...
Melanoma News Round-Up July 12, 2013
12 July 2013 In News
There was significant melanoma coverage in the healthcare, science, and medical world this week. Click on the following links to recap or to learn more. Experimental Melanoma Vaccine Shows Promise in Study via WebMD One Tumor Surprisingly More Deadly Than Multiple Melanomas via Medical News Today GSK files melanoma drug combination...
Melanoma Research Alliance Rings Closing Bell at the New York Stock Exchange
26 June 2013 In Events
[youtube url=http://www.youtube.com/watch?v=_Emq_T2GO5Y] We had a fabulous visibility opportunity yesterday: The Melanoma Research Alliance (MRA) rang the closing bell on the NYSE trading floor on Tuesday, June 25. Surrounded by MRA leadership and supporters, MRA Co-Founder and Chair Debra Black presided over the ceremony, which signaled the end of the day’s trading.
Changing Perceptions and Building a Business on Safe Sun: Guest Post by Mott 50
Mott 50 Co-Founders Anne Botica Reilly and Monique Moore[/caption] This summer Mott 50 is introducing the Pale is Pretty campaign— a social awareness initiative designed to encourage people to think critically about their sun safety practices and pledge to ‘Practice Safe Sun.’ Our mission at Mott 50 is to...
A Teenager’s View: Keeping Sun Fun and Avoiding Melanoma
By Langley Grace Wallace Over the past 40 years, melanoma has increased 800% in young women and 400% in young men. Recently, melanoma has become the most common cancer among 25-29 year olds, and even teenagers are developing this deadly skin cancer.
New Melanoma Stories
13 June 2013 In Melanoma Stories
Melanoma has touched the lives of many people, and MRA is always eager to hear melanoma stories from patients, researchers, family members, and everyone else affected by this disease. We've recently added two more must-read survivor stories to the MRA website, and here's a preview:
Two MRA-Sponsored Investigators Published Papers in the New England Journal of Medicine
12 June 2013 In News
Two MRA-sponsored investigators recently reported on the clinical testing of immune checkpoint inhibitors targeting a pathway known as PD-1 in the New England Journal of Medicine. This therapeutic approach, whose clinical utility was established by the FDA approval of ipilimumab in 2011, has produced promising data in patients with advanced melanoma.
Melanoma News Round-Up June 7, 2013
7 June 2013 In News
Promising New Cancer Drugs Empower the Body's Own Immune System via the New York Times MSK Researchers Report Major Advances in Treatment for Metastatic Eye and Skin Melanoma via Memorial Sloan Kettering Meet the New Class of Drugs Being Deployed in the the Struggle Against Cancer: Checkpoint Blockade via the Economist For a...
New Melanoma Therapies Approved
31 May 2013 In News
[caption id="attachment_200" align="aligncenter" width="576"] © Ladyminnie | Dreamstime Stock Photos & Stock Free Images[/caption] These are the best types of posts to write: On Wednesday, the US Food and Drug Administration (FDA) approved two genetically-targeted melanoma therapies as well as a companion diagnostic test that will be used to determine...
Accelerated Approval Advocacy Allies Anti-PD-1 ASCO Awareness Biopharma biopsy Board Members BRAF Cancer Capitol Hill Clinical Trials Collaborations Combination Therapies Combination Therapy Congress Corporate Partners Detection Diagnostics Drug Development Events Expanded Access Program FDA Francis Collins Funding Fundraising Genetics Health HHS immune checkpoint inhibitors Immunotherapies Immunotherapy Indoor Tanning ipilimumab Kids Legislation Leveraged Finance Fights Melanoma LFFM Louise Perkins May Medical Research Melanoma Melanoma Awareness Melanoma Awareness Month Melanoma Prevention Melanoma Research Melanoma Survivors MRA MRA Researchers News NIH Nonprofits Partnering Partnering For Cures Partnerships PASS Coalition Patient Advocacy Patient Story Patient-Centric Care Patients Pediatric Melanoma Policy Prevention Redheads Research research collaboration research funding research grants Researchers Science Sequestration skin biopsy Skin Cancer Skin Cancer Prevention Skin Checks Social Media Sun Safety Sunburn Sunscreen Sunscreen Innovation Act Surgeon General Surgeon General\'s Call to Action to Prevent Skin Cancer Survivor Story Tanning Tanning Bans Tanning Bed Tanning Bed Ban Tanning Beds targeted therapy Teens Treatment Treatments UPF Clothing Wendy Selig young investigator awards Young People